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onsumption of long-chain n-3 polyunsaturated fatty acids (n-3 PUFA)
is low among certain population subgroups in the United States, especially
in people living in Midwestern states
and those who dislike fish (7,8). Therefore, there is a need to identify acceptable food sources of n-3 PUFA. Vegetable oils, such as canola and soy,
provide some n-3 fatty acids. However, these sources are high in n-6
fatty acids and there is concern that
they may have detrimental side effects
(9). Eggs enriched in n-3 PUFA can be
produced by incorporating sources of
these fatty acids into poultry rations
(10,11). In acceptability studies, US
consumers responded positively to n-3
enriched eggs (12). However, Americans may be reluctant to consume eggs
as a source of n-3 PUFA because of
their cholesterol content.
Dietary intake of n-3 PUFA is associated with a reduced risk of primary
cardiac arrest and sudden and nonsudden death (1–4). The plantbased
form of n-3 PUFA, á linolenic acid
(LNA, 18:3n-3), may also reduce coronary heart disease (5). Harris (6) suggests that the effects of LNA and n6
fatty acids on serum lipids are similar, whereas marine n-3 PUFAs appear to raise low-density lipoprotein
(LDL) and high-density lipoprotein
levels and reduce serum triglycerides.
The n-3 PUFAs may have positive effects on serum lipids. Consumption of
a large dose (20 g/day) of n-3 PUFA
from fish oil significantly reduced both
serum triglycerides and total serum
cholesterol in patients with hyperlipidemia (13). Oh et al (14) reported that
persons with normal lipid levels who
consumed 4EPA and DHA-enriched
eggs per day reduced their serum triglyceride and blood pressure levels,
but there was no effect on total serum
cholesterol. People with normal lipid
levels who consumed 4 LNA-enriched
eggs per day experienced no signif-

icant effects on either serum triglycerides or total serum cholesterol (15).
There is a need to further assess the
role of eggs as a source of n-3 PUFA in
the US diet. The purpose of this study
was to evaluate the effects of the addition of LNA- and DHA-enriched eggs
on serum lipids of people with hyperlipidemia who were consuming a lowfat diet.
Methods
Twenty-five volunteers with hypercholesterolemia (serum cholesterol
>5.2 mmol/L*) were recruited from
the community. The participants—13
men and 12 women—ranged in age
from 26 to 73 years. None of the volunteers had been diagnosed with any
disease (including heart disease). The
project was approved by the Institutional Review Board at the University
of Nebraska, Lincoln. Volunteers were
randomly assigned to 3 experimental treatments: a low fat, self selected
diet with no eggs (no egg); a low-fat
self-selected diet with 12 n-3 PUFAenriched eggs per week (omega egg);
and a low-fat, self-selected diet with
12 control eggs per week (control egg).
A low-fat diet was defined as <30% of
energy from fat and <10% of energy
from saturated fat. A Latin square design was used so that all volunteers received each treatment during the 38week study. A 2-week baseline period
was followed by a 6-week, low-fat,
lead-in period before the first 6-week
diet treatment began. The order of the
diet treatments was randomized. Sixweek, low-fat, washout periods—during which no eggs were consumed—
were used between diet treatments.
After the baseline period, volunteers received nutrition counseling on
the low-fat diet by a registered dietitian once every 2 weeks. Body weight
was also monitored at each 2-week appointment. Volunteers received detailed instruction on estimating serv-

ing sizes and keeping complete food
records. They provided 3-day food records twice during each period (weeks
3 and 6). Week 3 food records were
used for monitoring and week 6 records were included in the data analysis. Food records were checked for
completeness and analyzed using the
Food Processor Plus computer program (ESHA version 6.0, Salem, Ore).
Mean daily energy, fat, and cholesterol consumption were determined
for each period. Blood samples were
drawn from fasting subjects twice during each period (weeks 4 and 6) and
serum lipid levels were determined
immediately at a certified medical laboratory (Nickols Institute, Lincoln,
Neb) using standardized laboratory
procedures.
The Department of Animal Science
at the University of Nebraska, Lincoln,
produced the eggs consumed during
the omega-egg and control-egg treatment periods. The n-3 PUFA-enriched
eggs were produced by including flaxseed in the poultry ration (12). The
n-3 PUFA content of the control egg
was 65 mg/egg and this increased to
412 mg/egg in the n-3 PUFA-enriched
egg. The majority of the increase in n-3
PUFA in the enriched egg was from
LNA, which increased from 17 mg/
egg in the control egg to 277 mg/egg
in the n-3 PUFA-enriched egg. The
DHA content of the n-3 PUFA-enriched egg also increased from 35 mg/
egg in the control egg to 114 mg/egg
in the n-3 PUFA-enriched egg.
The mean of the 2 serum samples
obtained from each volunteer during each treatment period was used
for data analysis. The general linear model procedure of SAS (version
6, 1994, SAS Institute, Gary, NC) was
used to compare treatment means using a repeated-measures analysis of
variance. Statistical analyses were also
used to identify if any treatment ordereffect was present. Mean change from

* To convert mmol/L cholesterol to mg/dL, multiply mmol/L by 38.7. To convert mg/dL cholesterol to mmol/L, multiply mg/dL by 0.026.
Cholesterol of 5.00 mmol/L=193 mg/dL.
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Table 1. Mean (±SEMa) serum lipidsb of volunteers consuming a no egg, n-3 PUFAc-enriched egg, or control egg low-fatd diet
treatment
Serum lipids

n-3 egge			

No egg			
Nonresponders
(n=23)

Control eggf

Nonresponders
Nonresponders Nonresponders Nonresponders Nonresponders
and responders
(n=23)
and responders (n=23)
and responders
(n=25)		
(n=25)		
(n=25)

Cholesterol (mmol/L)g
Total

5.92±0.07
5.90±0.07
		
LDL
3.88±0.06
3.87±0.06
			
HDL
1.24±0.02
1.22±0.02
			

6.00±0.06
0.08±0.20h
4.09±0.06
0.21±0.17
1.24±0.02
0.00±0.06

6.06±0.07
0.16±0.20
4.16±0.06**
0.29±0.17
1.21±0.02
0.01±0.06

5.92±0.07
0.00±0.20
3.98±0.06
0.10±0.17
1.26±0.02
0.02±0.06

5.97±0.07
0.07±0.20
4.05±0.06**
0.18±0.17
1.23±0.02
0.01±0.06

Triglycerides (mmol/L)i
1.73±0.09
1.76±0.08
			

1.46±0.09
0.27±0.25

1.50±0.09*
0.26±0.23

1.59±0.09*
0.14±0.25

1.60±0.08
0.16±0.23

a. SEM=standard error of the mean.
b. Mean of 2 serum samples obtained at weeks 4 and 6 of each period.
c. PUFA=polyunsaturated fatty acid.
d. Low-fat diet=< 30% of energy as fat, < 10% of energy as saturated fat.
e. 12 n-3 fatty acid-enriched eggs per week.
f. 12 standard eggs per week.
g. To convert mmol/L cholesterol to mg/dL, multiply mmol/L by 38.7. To convert mg/dL cholesterol to mmol/L, multiply mg/dL by 0.026.
Cholesterol of 5.00 mmo1/L=193 mg/dL. LDL=low-density lipoprotein. HDL=high-density lipoprotein.
h. Difference from no egg±SEM.
i. To convert mmol/L triglyceride to mg/dL, multiply mmol/L by 88.6. To convert mg/dL triglyceride to mmol/L, multiply mg/dL by 0.0113.
Triglyceride of 1.80 mmol/L=159 mg/dL.
* P < .05 (omega egg vs control egg).
** P < .01 (no egg vs omega egg and control egg combined).

Table 2. Dietary fat intakea (mean±SEMb) of volunteers consuming a self-selected low-fatc diet with no eggs, n-3 fatty acidenriched eggs or control eggs added (n=25)
Dietary fat						

Diet Treatment			

No egg

n-3 eggd

Control eggb

Total fat (% of energy)

21.5±0.64XZ

24.1±0.68

24.5±0.67

Saturated fatty acids (% of energy)

6.60±0.25y

7.30±0.26

7.86±0.26

Monounsaturated fatty acids (% of energy)

7.19±0.29XZ

8.97±0.32

9.32±0.31

Polyunsaturated fatty acids (% of energy)

5.07±0.26

5.56±0.28

4.93±0.28

n-3 Fatty acids (mg/d)

620±71X

1,420± 76Y

658±75

142±17.8XZ

468±19.1

481±18.8

Cholesterol (mg/d)

a. Mean of 3 days obtained at week 6 of each period.
b. SEM=standard error of the mean.
c. Low-fat diet=<30% of energy as fat, < 10% of energy as saturated fat.
d. 12 n-3 fatty acid-enriched eggs/week.
e. 12 standard eggs/week.
x. Different from n-3 egg P<.05
y. Different from control egg P<.0001
z. Different from control egg P<.05
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no egg to either n-3 egg or standard
egg was calculated.
Results and Discussion
Analysis of diet records indicated
that all 25 volunteers maintained a
low-fat diet throughout the treatment
and washout periods. Overall mean
daily total consumption and saturated
fat consumption for the 36 weeks were
22% and 7% of energy, respectively.
Mean daily cholesterol consumption was 142±18 mg/day on the noegg treatment and 475± 19 mg/day on
the omega-egg and control-egg treatments combined. Initial body mass
index of the volunteers was 25.7±2.9
(mean±SD) and results of weight monitoring indicated that this did not
change throughout the study. Analysis indicated that the order in which
the treatments were given had no effect. Two subjects did not have blood
samples for one treatment period. The
statistical analysis used accounts for
these missing data. Two volunteers
responded to the egg treatments with
an increase in total serum cholesterol
that was beyond 2 standard deviations
of the group mean. Data from these 2
volunteers were omitted from the column labeled “Nonresponders (n=23)”
in Table 1 but were included in the column labeled “Non responders and responders (n=25).”
There were no significant differences
in the effects of the dietary treatments
on any of the serum lipids in the nonresponders. However, when data from
responders were added to the analysis, there was a significant increase
in LDL cholesterol with the egg treatments (P<.01). There was a 7% increase in LDL cholesterol when omega
eggs were added and a 5% increase
when control eggs were added. For the
2 responders with the high total serum
cholesterol increase alone, corresponding increases in LDL cholesterol were
26% for omega eggs and 22% for control eggs (data not shown). Other researchers have also found that there is
a certain subset of the population that
is responsive to dietary cholesterol and
will therefore respond to an increase in
dietary cholesterol with an increase in
total and LDL serum cholesterol levels (16).
The most substantial change in serum lipid levels was in serum triglyceride levels, which were 16% lower on
the omega-egg diet treatment than on
the no-egg treatment. When responders (n=25) were added to the data
analysis, the difference in the decline
in serum triglycerides on the 2 types

of eggs became significant (P<.05).
The drop in serum triglycerides from
the no-egg treatment was 15% on the
omega-egg treatment and 9% on the
control-egg treatment.
Table 2 shows the effect on fat intake of the addition of the 12 eggs per
week. When eggs were added to the
low-fat diet, total fat, monounsaturated fatty acids, and cholesterol significantly increased (P<.05). Saturated
fat intake increased significantly on
the control-egg treatment but not on
the omega-egg treatment. When volunteers consumed the omega-egg dietary treatment, the intake of n-3
PUFA more than doubled.
Applications
Results of this research indicate that
the majority of people with hypercholesterolemia who are consuming a step
1 diet can add 12 eggs per week without experiencing a significant increase
in serum total or LDL cholesterol levels. However, a subset of this population is sensitive to dietary cholesterol
and their serum total and LDL cholesterol levels will increase with egg
consumption.
▪ The addition of 2 n-3 PUFA enriched
eggs per day as part of a low-fat
diet increases the total n-3 PUFA intake to approximately 1.4 g/day. If
n-3 PUFA-enriched eggs are recommended as a mechanism for increasing n-3 PUFA in the diet, serum cholesterol must be checked to ensure
that the patient does not respond to
the additional dietary cholesterol.
Dietetics professionals can monitor
the response of their patients to the
addition of eggs by taking a pre and
postmeasurement of serum cholesterol approximately 1 month apart.
▪ The n-3 enriched egg is an affordable
food source of n-3 PUFAs that is acceptable and easy to prepare for most
people. Three n-3 PUFA-enriched
eggs provide approximately the same
amount of n-3 fatty acids as one fish
meal (equivalent to 3 oz fish). The
number of n-3 PUFA-enriched eggs
recommended for a person will vary
with his or her current n-3 PUFA intake. It is recommended that n-3
PUFA-enriched eggs be used as one
source of n-3 PUFA to increase individual consumption, particularly in
people who seldom eat fish.
References
1. Albert, C.M., Hennekens, C.H., O’Donnell, C.J.,
Ajani, U.A., Carey, V.J., Willet, W.C., Ruskin, J.N.
and Manson, J.E., Fish consumption and risk of
sudden cardiac death. JAMA. 279, pp. 23–28.

367
2. Daviglus, M.L., Stamler, J., Orencia, A.J., Dyer,
A.R., Liu, K., Greenland, P., Walsh, M.K., Morris, D. and Shekelle, R.B., Fish consumption and
the 30-year risk of fatal myocardial infarction.
N Engl J Med. 336, pp. 1046–1053.
3. Siscovick, D.S., Raghunathan, T.E., King, I., Weinmann, S., Wicklund, K.G., Albright, J., Bovbjerg, V., Arbogast, P., Smith, H., Kushi, L.H.,
Cobb, L.A., Copass, M.K., Psaty, B.M., Lemaitre,
R., Retzlaff, B., Childs, M. and Knopp, R.H., Dietary intake and cell membrane levels of longchain n-3 polyunsaturated fatty acids and the
risk of primary cardiac arrest. JAMA. 274, pp.
1363–1367.
4. Nordoy, A., Bonaa, K.H., Nilsen, H., Berge, R.K.,
Hansen, J.B. and Ingebretsen, O.C., Effects
of Simvastatin and omega-3 fatty acids on
plasma lipoproteins and lipid peroxidation in
patients with combined hyperlipidaemia. J Intern Med. 243, pp. 163–170.
5. de Lorgeril, M., Renaud, S., Mamelle, N., Salen,
P., Martin, J.L., Monjaud, I., Guidollet, J.,
Touboul, P. and Delaye, J., Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 343,
pp. 1454–1459.
6. Harris, W.S., n-3 Fatty acids and serum lipoproteins: human subjects. Am J Clin Nutr. 65
suppl, pp. 1645S–1654S.
7. Lewis, N.M., Widga, A.C., Buck, J.S. and Frederick, A.M., Survey of omega-3 fatty acids in diets of midwest lowincome pregnant women. J
Agromedicine. 2, pp. 49–57.
8. Lewis, N.M., Albrecht, J.A., Schnepf, M.I., Hamouz, F.L., Driskell, J.A. and Goertz, J.A., Meat
choices and cookery methods of Nebraskans.
J Foodservice Systems. 8, pp. 165–174.
9. Kelly, F.J., The metabolic role of n-3 polyunsaturated fatty acids: relationship to human
disease. Comp Biochem Physiol. 98A, pp.
581–585.
10. Herber, S.M. and Van Elswyk, M.E., Dietary marine algae promotes efficient deposition of
n-3 fatty acids for the production of enriched
shell eggs. Poul Sci. 75, pp. 1501–1507.
11. Van Elswyk, M.E., Designer foods: manipulating
the fatty acid composition of meat and eggs
for the health conscious consumer. Nutr Today. 28, pp. 21–27.
12. ScheidelerSE, Froning G, Cuppett, S., Studies of
consumer acceptance of high omega-3 fatty
acid-enriched eggs. J Appl Poult Res. 6, pp.
137–146.
13. Phillipson, B.E., Rothrock, D.W., Connor, W.E.,
Harris, W.S. and Illingworth, D.R., Reduction
of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med. 312, pp.
1210–1216.
14. Oh, S.Y., Ryue, J., Hsieh, C. and Bell, D.E., Eggs
enriched in omega-3 fatty acids and alterations in lipid concentrations in plasma and lipoproteins and in blood pressure. Am J Clin
Nutr. 54, pp. 689–695.
15. Ferrier, L.K., Caston, L.J., Leeson, S., Squires,
J., Weaver, B.J. and Holub, B.J., Alpha-linolenic acid- and docosahexaenoic acid-enriched
eggs from hens fed flaxseed: influence on
blood lipids and platelet phospholipid fatty
acids in humans. Am J Clin Nutr. 62, pp. 81–86.
16. Katan, M.B. and Beynen, A.C., Characteristics of
human hypo- and hyperresponders to dietary
cholesterol. Am J Epidemiol. 125, pp. 387–399.

Acknowledgments — Partial funding was
provided by the Agricultural Research Division of the University of Nebraska-Lincoln (Journal Series No. 12264), the North
Dakota Oilseed Council, and the US Poultry and Egg Association.

